Abstract
BACKGROUND Hospital at Home (HaH) programs have been shown to be an effective care delivery model in diverse settings. Comparative effectiveness evaluations between HaH and traditional inpatient care for COVID-19 patients are limited. OBJECTIVE To test the effectiveness of care provided through Atrium Health-HaH compared to inpatient hospitalization for acutely ill patients with COVID-19. METHODS Retrospective matched sample comparative effectiveness study of 116 patients who presented to an emergency department and tested positive for COVID-19 at Atrium Health, a large integrated health care organization in the southeastern United States. Patients who were subsequently hospitalized between May 8 and June 25, 2020 (n = 58) were included in the control group, patients admitted to AH-HaH between July 15 and September 31, 2020 (n = 58) were included in the treatment condition. The primary outcome was 30-day composite of severe illness and death, indexed by the WHO illness severity scale. Patient demographic characteristics, comorbidities and hospital outcomes were collected from electronic health records. RESULTS 30-days post discharge, the number of patients who experienced severe illness or death was equivalent (n = 11/group; strata adjusted OR 1.0, 95% CI 0.37-2.69). CONCLUSIONS AH-HaH provides a feasible and efficacious alternative to traditional inpatient treatment for acutely ill patients with COVID-19.

This publication has 26 references indexed in Scilit: